A
Andres Duarte-Rojo
Researcher at University of Pittsburgh
Publications - 151
Citations - 6156
Andres Duarte-Rojo is an academic researcher from University of Pittsburgh. The author has contributed to research in topics: Medicine & Cirrhosis. The author has an hindex of 34, co-authored 124 publications receiving 4853 citations. Previous affiliations of Andres Duarte-Rojo include Toronto Western Hospital & University of Arkansas at Little Rock.
Papers
More filters
Journal ArticleDOI
Association between sustained virological response and all-cause mortality among patients with chronic hepatitis C and advanced hepatic fibrosis.
Adriaan J. van der Meer,Bart J. Veldt,Jordan J. Feld,Heiner Wedemeyer,Jean-François Dufour,Frank Lammert,Andres Duarte-Rojo,E. Jenny Heathcote,Michael P. Manns,L. Kuske,Stefan Zeuzem,W. Peter Hofmann,Robert J. de Knegt,Bettina E. Hansen,Harry L.A. Janssen +14 more
TL;DR: Among patients with chronic HCV infection and advanced hepatic fibrosis, sustained virological response to interferon-based treatment was associated with lower all-cause mortality.
Journal ArticleDOI
Feasibility and diagnostic performance of the FibroScan XL probe for liver stiffness measurement in overweight and obese patients
Robert P. Myers,Gilles Pomier-Layrargues,Richard Kirsch,Aaron Pollett,Andres Duarte-Rojo,David Wong,Melanie D. Beaton,Mark Levstik,Pam Crotty,Magdy Elkashab +9 more
TL;DR: Compared with the M probe, the FibroScan XL probe reduces TE failure and facilitates reliable LSM in obese patients, and lower liver stiffness cutoffs will be necessary when the XL probe is used to noninvasively assess liver fibrosis.
Journal ArticleDOI
Controlled Attenuation Parameter (CAP): a noninvasive method for the detection of hepatic steatosis based on transient elastography.
Robert P. Myers,Aaron Pollett,Richard Kirsch,Gilles Pomier-Layrargues,Melanie D. Beaton,Mark Levstik,Andres Duarte-Rojo,David Wong,Pam Crotty,Magdy Elkashab +9 more
TL;DR: The Controlled Attenuation Parameter (CAP) specifically targets liver steatosis using a process based on transient elastography that aims to reduce the number of errors in the detection of hepatic steatotic disease.
Journal ArticleDOI
Inclusion of Sarcopenia Within MELD (MELD-Sarcopenia) and the Prediction of Mortality in Patients With Cirrhosis
Aldo J. Montano-Loza,Andres Duarte-Rojo,Judith Meza-Junco,Vickie E. Baracos,Michael B. Sawyer,Jack X Q Pang,Crystal Beaumont,Nina Esfandiari,Robert P. Myers +8 more
TL;DR: Modification of the Model for End-Stage Liver Disease to include sarcopenia is associated with improved prediction of mortality in patients with cirrhosis, primarily in patientswith low MELD scores.
Journal ArticleDOI
A North American Expert Opinion Statement on Sarcopenia in Liver Transplantation
Elizabeth J. Carey,Jennifer C. Lai,Christopher J. Sonnenday,Elliot B. Tapper,Puneeta Tandon,Andres Duarte-Rojo,Michael A. Dunn,Cynthia Tsien,Eric R. Kallwitz,Vicky L. Ng,Srinivasan Dasarathy,Matthew R. Kappus,Mustafa R. Bashir,Aldo J. Montano-Loza +13 more
TL;DR: The management of sarcopenia requires a multipronged approach including nutrition, exercise, and additional pharmacological therapy as deemed necessary as well as how improvement in muscle mass might be associated with improvement in clinical outcomes.